Market Wire - Pharmaceuticals and Biotech

Paladin Labs Inc. and Procter & Gamble Pharmaceuticals Canada Inc.: Paladin Labs and Procter & Gamble Pharmaceuticals Enter Into Canadian Co-P - July 2, 2008

MONTREAL, QUEBEC (MARKET WIRE) Paladin Labs Inc. (TSX: PLB) and Procter & Gamble (P&G) Pharmaceuticals Canada, Inc., today announced that the companies have entered into a Canadian Co-Promotion Agreement for SEASONALE(TM) - the first and only extended-cycle oral contraceptive available in Canada. With SEASONALE(TM), Canadian women have an oral contraceptive option that will allow them to have just four periods per year.
http://www2.marketwire.com/mw/release_html_b1?release_id=412722&tsource=3

Chemokine Therapeutics Corp.: Chemokine Therapeutics Announces Issuance of U.S. Patent - July 2, 2008

VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that it has been granted U.S. Patent No. 7,378,098.
http://www2.marketwire.com/mw/release_html_b1?release_id=412454&tsource=3

Protherics PLC: Protherics PLC announces Total Voting Rights - July 2, 2008

CHESHIRE, UK (MARKET WIRE)
http://www2.marketwire.com/mw/release_html_b1?release_id=412407&tsource=3

ONI BioPharma Inc.: ONI BioPharma Appoints New Chief Operational Officer - July 1, 2008

ALACHUA, FL (MARKET WIRE) ONI BioPharma Inc. (AMEX: ONI), a biopharmaceutical company, today announced that David B. Hirsch has been appointed to Chief Operating Officer and Chief Financial Officer to succeed Dorothy Delfino, who is retiring from the Company. Mr. Hirsch began working for the company as a consultant in April of this year and joined the Company as a full-time employee in May. Ms. Delfino will remain with the Company on a consultant basis.
http://www2.marketwire.com/mw/release_html_b1?release_id=412303&tsource=3

SinoFresh HealthCare, Inc.: SinoFresh Announces "Next Step" in Program to Attack "Super-Bug" MRSA - July 1, 2008

VENICE, FL (MARKET WIRE) SinoFresh HealthCare, Inc. (OTCBB: SFSH), the makers of SinoFresh Nasal Spray, announced today the next step in a research and development program expected to lead to a nasal spray product for attacking MRSA -- the so-called "super bug" -- reservoirs in the nasal passage. These nasal reservoirs are believed by public health experts to be a significant source of MRSA infections. "This continuation of an earlier study is a concrete expression of SinoFresh's commitment to.
http://www2.marketwire.com/mw/release_html_b1?release_id=412197&tsource=3

Pink Sheets LLC: QRxPharma Joins International OTCQX - July 1, 2008

NEW YORK, NY (MARKET WIRE) Pink OTC Markets Inc., the leading electronic inter-dealer quotation system, trading technology and financial information provider for over-the-counter (OTC) securities, today announced that QRxPharma (PINKSHEETS: QRXPY) (OTCQX: QRXPY), a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapies for pain and central nervous system (CNS) disorders, has chosen to list its American Depositary Receipts (ADR) on...
http://www2.marketwire.com/mw/release_html_b1?release_id=412129&tsource=3

Conformia: FDA Expands Cooperative Research and Development Study (CRADA) With Conformia - July 1, 2008

SUNNYVALE, CA (MARKET WIRE) Conformia, the market leader of product and process lifecycle management (PPLM) solutions for life sciences, today announced the U.S. Food and Drug Administration's (FDA) Office of Pharmaceutical Sciences (OPS) has asked the Company to expand its Cooperative Research and Development Study (CRADA) focusing on process and product development to 25 companies. The CRADA Research Study is helping to uncover the challenges facing pharmaceutical, biotechnology, and...
http://www2.marketwire.com/mw/release_html_b1?release_id=411959&tsource=3

DIREVO Biotech AG: DIREVO and DaniscoGenencor Sign Second Cooperation Agreement - July 1, 2008

COLOGNE, GERMANY (MARKET WIRE) DIREVO Biotech AG and Genencor Division of Danisco AS today announced the signing of their second collaboration agreement.
http://www2.marketwire.com/mw/release_html_b1?release_id=412115&tsource=3

UCB: UCB's Cimzia(R) filed with EMEA for treatment of rheumatoid arthritis - July 1, 2008

BRUSSELS, BELGIUM (MARKET WIRE)
http://www2.marketwire.com/mw/release_html_b1?release_id=412099&tsource=3

Geneart AG: The US National Cancer Institute Expands Contract with GENEART by USD 0.8M - July 1, 2008

REGENSBURG, GERMANY (MARKET WIRE)
http://www2.marketwire.com/mw/release_html_b1?release_id=412098&tsource=3